HOME > ARCHIVE
ARCHIVE
- Wholesalers Environment to Be Tougher This Year: EAD Director
January 21, 2002
- First Survey on Diabetic Neuropathy Conducted in Japan: JPA
January 21, 2002
- NHI Price System Reform to Give Incentives to New Drugs: PFSB Director General
January 21, 2002
- Korosho Starts Research to Clarify Causes of 3 Severe ADRs
January 21, 2002
- Birth Rate Lowest Ever Recorded, Continuing Trend of Fewer Children
January 21, 2002
- University of Tokyo to Abolish Master Degree System
January 21, 2002
- REGULATORY NEWS IN BRIEF
January 21, 2002
- Criteria for Compensation for AE Sustained in Clinical Trials Needed: JSCPT
January 21, 2002
- Foreign Firm Are Enthusiastic about Increasing Number of MRs: Survey
January 21, 2002
- NEDO Selects Technology Research Projects for Funding in 2001
January 21, 2002
- Use of Celera Genomics Database Expanding in Japan
January 21, 2002
- Pharmacy-based Pharmacists Show Sharp Increase: Medical Professional Survey
January 21, 2002
- Company Leaders Express Commitment to Reform: New Year Addresses
January 21, 2002
- Results of Survey on Clinical Studies Announced
January 21, 2002
- BUSINESS NEWS IN BRIEF
January 14, 2002
- Price Cutting Rates for Long-listed Drugs Likely to Be 3-tiered
January 14, 2002
- Vital-Net to Acquire Shares of Inoue Seishodo
January 14, 2002
- Home Caregivers of Dementia Patients under Severe Stress: Eisai, Pfizer Seminar
January 14, 2002
- Korosho Budget Totals \18,668.4 Bil., Up 3.2%
January 14, 2002
- Fukujin Takes Over Ethical Drugs, Lab Reagents from Inagaki
January 14, 2002
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
